Literature DB >> 18378378

Hyperecho as the indicator of tissue necrosis during microbubble-assisted high intensity focused ultrasound: sensitivity, specificity and predictive value.

Tinghe Yu1, Chuanshan Xu.   

Abstract

The purpose of this study was to determine the sensitivity, specificity and predictive values of hyperecho in grayscale ultrasonic images as the indicator of tissue necrosis in microbubble-assisted high-intensity focused ultrasound (HIFU) exposure in vivo. Livers and kidneys of the rabbit were exposed to HIFU (control group) or microbubble-assisted HIFU (experimental group); a continuous line of ablation, viz. linear scan, was performed to destruct tissues. Tissue responses were evaluated macroscopically and microscopically 24 h after HIFU. The cases of positive (hyperecho occurred and tissue necrotized), false positive (tissue was unaffected although hyperecho appeared), negative (echo was not changed and tissue was intact) and false negative (tissue was destructed despite the lack of hyperecho) were counted, and then the sensitivity, specificity and positive and negative predictive values of hyperecho were calculated. The sensitivity, specificity, positive predictive value and negative predictive value were 49.25% vs. 79.63% (p < 0.001), 45.45% vs. 30.00%, 84.62% vs. 86.00% and 12.82% vs. 21.43% for liver and 76.06% vs. 81.25%, 26.53% vs. 41.67%, 60.00% vs. 82.28% (p = 0.002) and 43.33% vs. 40.00% for kidney, in control and experimental groups, respectively. Rates varied between tissue types in control group. These findings indicated that the use of microbubble during HIFU improved the sensitivity in liver and the positive predictive value in kidney. The specificity and negative predictive value were poor. Hyperecho could only be used as the indicator of tissue necrosis in some tissue types.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18378378     DOI: 10.1016/j.ultrasmedbio.2008.01.012

Source DB:  PubMed          Journal:  Ultrasound Med Biol        ISSN: 0301-5629            Impact factor:   2.998


  8 in total

1.  Prevention of post-focal thermal damage by formation of bubbles at the focus during high intensity focused ultrasound therapy.

Authors:  Vesna Zderic; Jessica Foley; Wenbo Luo; Shahram Vaezy
Journal:  Med Phys       Date:  2008-10       Impact factor: 4.071

2.  Microbubbles improve the ablation efficiency of extracorporeal high intensity focused ultrasound against kidney tissues.

Authors:  Tinghe Yu; Dingrong Hu; Chuanshan Xu
Journal:  World J Urol       Date:  2008-07-02       Impact factor: 4.226

3.  Analysis of tissue changes, measurement system effects, and motion artifacts in echo decorrelation imaging.

Authors:  Fong Ming Hooi; Anna Nagle; Swetha Subramanian; T Douglas Mast
Journal:  J Acoust Soc Am       Date:  2015-02       Impact factor: 1.840

4.  Fast lesion mapping during HIFU treatment using harmonic motion imaging guided focused ultrasound (HMIgFUS) in vitro and in vivo.

Authors:  Yang Han; Shutao Wang; Thomas Payen; Elisa Konofagou
Journal:  Phys Med Biol       Date:  2017-03-21       Impact factor: 3.609

5.  Using passive cavitation images to classify high-intensity focused ultrasound lesions.

Authors:  Kevin J Haworth; Vasant A Salgaonkar; Nicholas M Corregan; Christy K Holland; T Douglas Mast
Journal:  Ultrasound Med Biol       Date:  2015-06-04       Impact factor: 2.998

6.  Adverse events of extracorporeal ultrasound-guided high intensity focused ultrasound therapy.

Authors:  Tinghe Yu; Jun Luo
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240

7.  The Value of Proton Magnetic Resonance Spectroscopy in High-Intensity Focused Ultrasound Treatment of Experimental Liver Cancer.

Authors:  Zhuo-Yue Tang; Jian-Nong Zhao; Wei-Jia Zhong; Yin-Deng Luo; Wei Wu; Wei-Juan Chen; Yu-Bing Dai
Journal:  Transl Oncol       Date:  2015-06       Impact factor: 4.243

Review 8.  Magnetic resonance image-guided versus ultrasound-guided high-intensity focused ultrasound in the treatment of breast cancer.

Authors:  Sheng Li; Pei-Hong Wu
Journal:  Chin J Cancer       Date:  2012-12-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.